entertainment -WSS

entertainment

author：comprehensive 2025-09-07 14:01:29 - browse：22

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： More doctors should go into startup world

focus

explore

WSS

Pandemic and All Hazards Preparedness Act needs lean update

Study: New antibiotic targets gonorrhea as well as last existing drug

UCSF medical school apologizes for unethical prisoner experiments

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Victims of gun violence feel impacts long after bullet wound

Biden targets hefty hospital 'facility fees' that often surprise patients

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Moonlake's readout produced a cash windfall. Risks remain

Will General Catalyst be the first of many hospital takeovers?

Hepatitis C has a cure — but many Americans still lack access to it

Teachers share how revamped forgiveness program helped with their student loans

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ambulance rides for just $100? Advisers want major billing fixes

Apple is now the first public company to be valued at $3 trillion

Create a giant ice tray with this foil pan hack to keep food cold this summer

How one medical school became remarkably diverse

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

entertainment

Home health providers sue Medicare over payment cuts

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Removing probiotics from the NICU could threaten preemies' health

Medicare wants to send $9 billion to 340B hospitals

Teachers share how revamped forgiveness program helped with their student loans

Judge agrees to delay next hearing in Trump classified documents case

focus

entertainment

explore

hotspot